Hacker News new | past | comments | ask | show | jobs | submit login

I completely agree you have to include cost of failed candidates and did not mean to suggest I did not

I mentioned the cash costs for developing an approved drug as an additional data point to that illustrate GPs $35M is too low even excluding cost of failure




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: